State of Wisconsin Investment Board

SWIB's investments are managed by its own professional staff and by outside money manager firms. SWIB is required to make investment management decisions for the pension funds solely for the benefit of the members of the Wisconsin Retirement System (WRS). As fiduciaries of the pension funds, SWIB staff and Trustees are required to use the diligence, skill and care that a prudent investor would use in managing a large public pension fund. Trustees are responsible for determining SWIB's overall investment management policies. Selection of individual investments is in the hands of staff and external money management firms. Both must make investment decisions based on extensive research, detailed analytics and judgment based on risks and potential returns. The rate of return and risk are evaluated when considering asset classes and the individual investments.
C(

Chuck (Charles) Carpenter

MD, Private Markets

JC

John Culley

Associate Portfolio Manager

AF

Anne-Marie Fink

Private Markets and Funds Alpha CIO

RK

Rochelle Klaskin

Deputy Executive Director / Chief Administrative Officer

David Villa

CIO

25 past transactions

NeuWave Medical

Series B in 2012
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.

Neurovance

Venture Round in 2012
Neurovance, Inc., a neuroscience-focused company, focuses on the development and commercialization of therapies for adult and children with attention deficit hyperactivity disorders. The company develops centanafadine, a triple reuptake inhibitor that modulates the activity of norepinephrine dopamine and serotonin in a specific ratio. Neurovance, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts. As of March 31, 2017, Neurovance, Inc. operates as a subsidiary of Otsuka America, Inc..

HistoSonics

Series C in 2020
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels.

NeuWave Medical

Series C in 2015
NeuWave Medical develops tools that deliver energy to the human body to treat a variety of serious medical conditions. Their company founders are both engineers and physician-scientists which allows determining a clinical need and design solutions that are clinically relevant, effective, and minimally invasive. They strive to make the highest quality devices that are the products of choice for leading physicians and medical centers around the world. The company was founded in 2004 and is headquartered in Madison, Wisconsin.

EatStreet

Series C in 2015
EatStreet is an online and mobile food ordering service that streamlines commerce between restaurants and diners. To college students and young professionals, EatStreet is a smart, simple, and affordable way to order delivery and takeout from their favorite restaurants. To restaurant owners, EatStreet is a one-stop-shop for online ordering and marketing. By providing web, mobile, and social products for online ordering, EatStreet brings in new business for restaurants. Diners enjoy the upside of fast, simple ordering while restaurants see their sales soar. Founded in 2010, the company is headquartered in Madison, Wisconsin, United States.

Roche NimbleGen

Series D in 2003
Roche NimbleGen provides products and services to the life science research market. The company offers SeqCap EZ system, a solution-based capture system that enables enrichment of exome in a single test tube; SeqCap EZ library that covers exome designs, gene panels, and custom content designs; and SeqCap EZ reagents to maximize workflow and order different reagent needs. It also provides SeqCap Epi, an enrichment system that includes a set of target enrichment tools for DNA methylation assessment at single-base resolution, as well as offers SeqCap Epi kits and reagents. The company provides a set of preparation and adapter kits for library construction including SignalMap, a software product for browsing of genomic tracks; and NimbleDesign, an online tool that enables users to design SeqCap EZ choice libraries. It offers DNA microarray products and services for CGH, ChIP-chip, DNA methylation, AccuSNP, CGS, instruments, sequence capture arrays, gene expression microarrays, and their associated workflows. The company also provides online technical and instruction support services. Roche NimbleGen was founded in 1999 and is headquartered in Madison, Wisconsin. As of August 8, 2007, Roche NimbleGen operates as a subsidiary of Roche Holding AG.

Madison Vaccines, Inc.

Series A in 2015
Madison Vaccines, Inc., a biopharmaceutical company, develops therapeutic plasmid DNA vaccines. It focuses on bone metastases and prostate cancer. The company is based in United States.

Pinstripe

Series A in 2005
Pinstripe is a top RPO provider with global reach and high customer satisfaction as recognized by HRO Today’s Baker’s Dozen. They serve world-class organizations in financial services, healthcare, pharmaceuticals, technology, advanced manufacturing, biotech, telecommunications and energy.

FluGen, Inc.

Venture Round in 2016
FluGen, Inc. develops vaccines that prevents from the diseases caused by influenza viruses. It offers RedeeFlu, a nasal spray vaccine used to protect against influenza and vaccine-loaded intradermal microneedle delivery device. The company was founded in 2007 and is based in Madison, Wisconsin.

FluGen, Inc.

Series A in 2017
FluGen, Inc. develops vaccines that prevents from the diseases caused by influenza viruses. It offers RedeeFlu, a nasal spray vaccine used to protect against influenza and vaccine-loaded intradermal microneedle delivery device. The company was founded in 2007 and is based in Madison, Wisconsin.

Zystor

Series A in 2004
ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal storage diseases.

EatStreet

Series B in 2014
EatStreet is an online and mobile food ordering service that streamlines commerce between restaurants and diners. To college students and young professionals, EatStreet is a smart, simple, and affordable way to order delivery and takeout from their favorite restaurants. To restaurant owners, EatStreet is a one-stop-shop for online ordering and marketing. By providing web, mobile, and social products for online ordering, EatStreet brings in new business for restaurants. Diners enjoy the upside of fast, simple ordering while restaurants see their sales soar. Founded in 2010, the company is headquartered in Madison, Wisconsin, United States.

OpGen

Series B in 2005
OpGen, Inc is a privately-held company, based in Gaithersburg, MD, and focused on commercializing rapid, high precision solutions for DNA analysis and genomics with the Argus® Whole Genome Mapping System and MapIt® Services. Using the proprietary technologies provided by OpGen, customers in academic, government, biodefense and research labs as well as premier genome centers around the world can view ordered whole genome maps for a wide range of applications including strain typing for early outbreak response, improved sequence assembly of microbial and now large genomes up to 3 Gb and comparative genomics applications. OpGen Community (Linkedin Group) provides an accessible environment to share information, exchange questions and best practices using OpGen’s technologies in a variety of applications.

Cardiac Pathways Corp

Venture Round in 2000
Cardiac Pathways Corp manufactures minimally-invasive systems used by electrophysiologists to diagnose and treat cardiac tachyarrhythmia (abnormally rapid heart rhythms), which if untreated can cause palpitations, fainting, and sudden cardiac arrest. Cardiac Pathways' products consist principally of systems for performing ablation treatment (a nonsurgical, minimally-invasive technique for neutralizing heart tissue responsible for starting or maintaining a tachyarrhythmia) and for diagnostic mapping (locating the source of the tachyarrhythmia within the heart). Cardiac Pathways was issued a U.S. patent related to its Real-time Position Management Tracking System. Founded in 1991, Cardiac Pathways is based in Sunnyvale, California. As of August 6, 2001, it was acquired by Boston Scientific Corporation.

Zurex Pharma

Series B in 2014
Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Montage

Series B in 2012
Montage Talent, Inc. provides live and on-demand voice and video interviewing solutions for large enterprises, healthcare industries, and staffing and recruitment process outsourcing vendors. Montage Talent, Inc. was formerly known as Expressume, Inc. and changed its name to Montage Talent, Inc. in May 2001. The company was founded in 2007 and is based in Delafield, Wisconsin. As of May 21, 2019, Montage Talent, Inc. operates as a subsidiary of Shaker International.

ABODO

Venture Round in 2015
Rentable is an internet company that specializes in providing a web-based platform that allows its users to conduct an online internet apartment search. The company was established in 2011 and is based in Madison, Wisconsin.

Mithridion

Series B in 2009
Mithridion is a biopharmaceutical company that discovers and develops drugs for central nervous system disorders, with an initial focus on Alzheimer's disease and schizophrenia.

Neurovance

Series A in 2014
Neurovance, Inc., a neuroscience-focused company, focuses on the development and commercialization of therapies for adult and children with attention deficit hyperactivity disorders. The company develops centanafadine, a triple reuptake inhibitor that modulates the activity of norepinephrine dopamine and serotonin in a specific ratio. Neurovance, Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts. As of March 31, 2017, Neurovance, Inc. operates as a subsidiary of Otsuka America, Inc..

Datica

Venture Round in 2014
Datica helps highly regulated industries manage sensitive information in the cloud. The Datica Platform complies with HIPAA, HITRUST, GDPR, GxP, and more by providing a secure, compliant Kubernetes managed service that integrates with additional cloud services. Datica customers range from mid-to-late-stage startups to Fortune 100 companies. For more information, visit datica.com.

Madison Vaccines, Inc.

Series A in 2014
Madison Vaccines, Inc., a biopharmaceutical company, develops therapeutic plasmid DNA vaccines. It focuses on bone metastases and prostate cancer. The company is based in United States.

Roche NimbleGen

Series B in 2001
Roche NimbleGen provides products and services to the life science research market. The company offers SeqCap EZ system, a solution-based capture system that enables enrichment of exome in a single test tube; SeqCap EZ library that covers exome designs, gene panels, and custom content designs; and SeqCap EZ reagents to maximize workflow and order different reagent needs. It also provides SeqCap Epi, an enrichment system that includes a set of target enrichment tools for DNA methylation assessment at single-base resolution, as well as offers SeqCap Epi kits and reagents. The company provides a set of preparation and adapter kits for library construction including SignalMap, a software product for browsing of genomic tracks; and NimbleDesign, an online tool that enables users to design SeqCap EZ choice libraries. It offers DNA microarray products and services for CGH, ChIP-chip, DNA methylation, AccuSNP, CGS, instruments, sequence capture arrays, gene expression microarrays, and their associated workflows. The company also provides online technical and instruction support services. Roche NimbleGen was founded in 1999 and is headquartered in Madison, Wisconsin. As of August 8, 2007, Roche NimbleGen operates as a subsidiary of Roche Holding AG.

FluGen, Inc.

Series A in 2015
FluGen, Inc. develops vaccines that prevents from the diseases caused by influenza viruses. It offers RedeeFlu, a nasal spray vaccine used to protect against influenza and vaccine-loaded intradermal microneedle delivery device. The company was founded in 2007 and is based in Madison, Wisconsin.

Datica

Series A in 2013
Datica helps highly regulated industries manage sensitive information in the cloud. The Datica Platform complies with HIPAA, HITRUST, GDPR, GxP, and more by providing a secure, compliant Kubernetes managed service that integrates with additional cloud services. Datica customers range from mid-to-late-stage startups to Fortune 100 companies. For more information, visit datica.com.